Bethany Beazley

Appearances

DUPILUMAB IMPROVES HISTOLOGIC AND ENDOSCOPIC ASPECTS OF EOSINOPHILIC ESOPHAGITIS IN CHILDREN AGED 1-11 YEARS IN THE PHASE 3 EOE KIDS TRIAL
Date
May 8, 2023
This session presents the best submitted clinical abstracts as determined by their specific council sections…
Presenter
Mirna Chehade
Speakers
Evan Dellon
University of North Carolina School of Medicine
Jonathan Spergel
Marc Rothenberg
Ruiqi Liu
Leda Mannent
Elizabeth Laws
Eric Mortensen
Jennifer Maloney
Faisel Khokhar
Bethany Beazley
Lila Glotfelty
Arsalan Shabbir
DUPILUMAB IMPROVES HISTOLOGIC, SYMPTOMATIC, AND ENDOSCOPIC ASPECTS OF EOSINOPHILIC ESOPHAGITIS, REGARDLESS OF PRIOR HISTORY OF ESOPHAGEAL DILATION
Date
May 7, 2023
BACKGROUND: Novel treatment options for eosinophilic esophagitis (EoE) are needed. Previous studies have assessed mepolizumab (mepo), a monoclonal antibody against IL-5, with mixed results in EoE, and the efficacy of mepo in an adult and adolescent population has yet to be fully examined…
Presenter
Arjan Bredenoord
Amsterdam UMC, University of Amsterdam
Speakers
Evan Dellon
University of North Carolina School of Medicine
Ikuo Hirano
Xian Sun
Elizabeth Laws
Eric Mortensen
Leda Mannent
Jennifer Maloney
Lila Glotfelty
Bethany Beazley
Arsalan Shabbir